Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
Clinical and bacteriological features of pneumonia associated with lung cancer (LC) Source: Eur Respir J 2003; 22: Suppl. 45, 253s Year: 2003
Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006
Lung cancer in men compared with women: presentation, management, histologic characteristics and staging Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care. Source: International Congress 2019 – Treatment of lung cancer Year: 2019
The utilization pattern of surgical lung biopsies (SLB) for the diagnosis of interstitial lung diseases (ILD) in Sri Lanka Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The prevalence of metastasis to the aortopulmonary window lymph nodes (stations 5 and 6) in patients with left lung carcinoma: A retrospective analysis of 566 patients Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Predictors of major serious manifestations in the terminal stage of lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
The histological confirmation rate of lung cancer in the UK using the NLCA database Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012
A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Cyst-related primary lung malignancies: an important and relatively unknown imaging appearance of (early) lung cancer Source: Eur Respir Rev, 27 (150) 180079; 10.1183/16000617.0079-2018 Year: 2018
Comparative analysis of lung tuberculosis (LTB) and lung cancer (LC) patients‘ smoking habits Source: Eur Respir J 2004; 24: Suppl. 48, 151s Year: 2004